Thrombocytopenia, characterized by abnormally low platelet counts in circulating blood, is caused by decreased platelet production and/or accelerated platelet destruction [1]. The main concept in treating thrombocytopenia is to eliminate the cause of the accelerated platelet destruction or increase platelet counts by stimulating the production of new platelets [2]. Thrombopoietin receptor (TPOR) is recognized as an ideal target for the treatment of thrombocytopenia [3].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with K.
Contact K., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack